Genetic predisposition to multiple sclerosis as revealed by immunoprinting

Annals of Neurology

Volumn 41, Issue 3, 1997, Pages 341-352

  Epplen, Cornelia ^a,e   Jäckel, Silke ^a   Santos, Eduardo J M ^a   D'Souza, Marcus ^a   Poehlau, Dieter ^a   Dotzauer, Bernd ^a   Sindern, Eckhart ^b   Haupts, Michael ^c   Rüde, Klaus Peter ^c   Weber, Frank ^d   Stöver, Jens ^d   Poser, Sigrid ^d   Gehler, Walter ^c   Malin, Jean Pierre ^b   Przuntek, Horst ^a   Epplen, Jörg T ^a  

^a Chirurgische Klinik   (Germany)

^b RUHR UNIVERSITY BOCHUM   (Germany)

^c RUHR UNIVERSITY BOCHUM   (Germany)

^d UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^e RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; HLA DR ANTIGEN; INTERFERON; MICROSATELLITE DNA; T LYMPHOCYTE RECEPTOR;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISABILITY; DISEASE COURSE; DISEASE DURATION; DNA DETERMINATION; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; HLA TYPING; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PATHOGENESIS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BASE SEQUENCE; CHILD; CYTOKINES; DISEASE SUSCEPTIBILITY; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HLA ANTIGENS; HUMANS; LINKAGE (GENETICS); MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTORS, CYTOKINE; RISK FACTORS; T-LYMPHOCYTES;

EID: 1842410720     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410410309     Document Type: Article

References (62)

1. Martin R, McFarland HF, McFarlin DE. Immunological aspects of demyelinating diseases. Annu Rev Immunol 1992;10: 153
2. Ebers GC, Bulman DE, Sadovnick AD, et al. A population-based study of multiple sclerosis in twins. N Engl J Med 1986; 315:1638-1642
3. Ebers GC, Sadovnick AD, Risch NJ, Canadian Collaborative Study Group. A genetic basis for familial aggregation in multiple sclerosis. Nature 1995;377:150-151
4. Warren KG, Catz I, Steinman L. Fine specificity of the antibody response to myelin basic protein in the central nervous system in multiple sclerosis: the minimal B-cell epitope and a model of its features. Proc Natl Acad Sci USA 1995;92:11061-11065
5. Olerup O, Hillert J. HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. Tissue Antigens 1991;38:1-15
6. Spurkland A, Ronningen KS, Vandvik B, et al. HLA-DQA1 and HLA-DQB1 genes may jointly determine susceptibility to develop multiple sclerosis. Hum Immunol 1991;30:69-75
7. Begovich AB, McClure GR, Suraj VC, et al. Polymorphism, recombination, and linkage disequilibrium within the HLA class II region. J Immunol 1992;148:249-258
8. Liblau R, van Endert PM, Sandberg-Wollheim M, et al. Antigen processing gene polymorphisms in HLA-DR2 multiple sclerosis. Neurology 1993;43:1192-1197
9. Kellar-Wood HF, Powis SH, Gray J, Compston DAS. MHC-encoded TAP1 and TAP2 dimorphisms in multiple sclerosis. Tissue Antigens 1994;43:129-132
10. Compston DAS, Kellar Wood H, Robertson N, et al. Genes and susceptibility to multiple sclerosis. Acta Neurol Scand Suppl 1995;161:43-51
11. Beall SS, Biddison WE, McFarlin DE, et al. Susceptibility for multiple sclerosis is determined, in part, by inheritance of a 175-kb region of the TCR Vβ chain locus and HLA class II genes. J Neuroimmunol 1993;45:53-60
12. Wei S, Charmley P, Birchfield RI, Concannon P. Human T cell receptor Vβ gene polymorphism and multiple sclerosis. Am J Hum Genet 1995;56:963-969
13. Fugger L, Morling N, Sandberg-Wollheim M, et al. Tumor necrosis factor alpha gene polymorphism in multiple sclerosis and optic neuritis. J Neuroimmunol 1990;27:85-88
14. Roth MP, Nogueira L, Coppin H, et al. Tumor necrosis factor polymorphisms in multiple sclerosis: no additional association independent of HLA. J Neuroimmunol 1994;51:93-99
15. Gomolka M, Hundrieser J, Nürnberg P, et al. Selected di- and tetranucleotide microsatellites from chromosomes 7, 12, 14, and Y in various Eurasian populations. Hum Genet 1994;93: 592-596
16. Cornelis F, Hashimoto L, Loveridge J, et al. Identification of a CA repeat at the TCRA locus using yeast artificial chromosomes: a general method for generating highly polymorphic markers at chosen loci. Genomics 1992;13:820-825
17. Gomolka M, Menninger H, Saal JE, et al. Immunoprinting: various genes are associated with increased risk to develop rheumatoid arthritis in different groups of adult patients. J Mol Med 1995;73:19-29
18. Chasseval de R, Villartay de JP. Functional characterization of the promoter for the human germ-line T cell receptor Jα (TEA) transcript. Eur J Immunol 1993;23:1294-1298
19. Epplen C, Rumpf H, Albert E, et al. Immunoprinting excludes many potential susceptibility genes as predisposing to early onset pauciarticular juvenile chronic arthritis except HLA class II and TNF. Eur J Immunogenet 1995;22:311-322
20. Suzuki H, Kündig TM, Furlonger C, et al. Deregulated T cell activation and autoimmunity in mice lacking interleukin-2 receptor β. Science 1995;268:1472-1476
21. Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G. Structural characterization and biological functions of fibroblast growth factor. Endocr Rev 1987;8:95-114
22. Poser CM, Paty DW, Scheinberg L, et al. New diagnostic criteria for multiple sclerosis. Ann Neurol 1983;13:227-231
23. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983;33: 1444-1452
24. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215
25. Kroef MJPL, Willemze R, Landegent JE. Dinucleotide repeat polymorphism in the Interferon regulating factor 1 (IRF1) gene. Hum Mol Genet 1993;2:1748
26. Ruiz-Linares A. Dinucleotide repeat polymorphism in the interferon-gamma (IFNG) gene. Hum Mol Genet 1993;2:1508
27. Gnarra JR, Otani H, Wang MG, et al. The human interleukin 2 receptor beta chain gene: chromosomal localization and identification of 5′ regulatory sequences. Proc Natl Acad Sci USA 1990;87:3440-3444
28. Tarlow JK, Blakemore AI, Lennard A, et al. Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet 1993; 91:403-404
29. Marsh SGE, Bodmer JG. HLA class II nucleotide sequences, 1992. Immunogenetics 1993;37:79-94
30. Riess O, Kammerbauer C, Roewer L, et al. Hypervariability of intronic simple (gt)n(gt)m repeats in HLA-DRB genes. Immunogenetics 1990;32:110-116
31. Bodmer JG, Marsh SGE, Albert ED, et al. Nomenclature for factors of the HLA system, 1994. Eur J Immunogenet 1994; 21:485-517
32. Svejgaard A, Ryder LP. HLA and disease associations: detecting the strongest association. Tissue Antigens 1994;43:18-27
33. Arnold A, Albert ED, Computerprogramm zur Berechnung von Haplorypfrequenzen des HLA Systems. Zeit Immunoforsch 1976;152:407-415
34. Hansen HE, Larsen SO, Ryder LP, Nielson LS. HLA-A,B haplotype frequencies in 5,202 unrelated Danes by a maximum-likelihood method of gene counting. Tissue Antigens 1979;13: 143-153
35. Wilson AG, Symons JA, McDowell TL, et al. Effects of a tumor necrosis factor (TNFα) promoter base transition on transcriptional activity. Br J Rheumatol 1994;33(suppl 1):89
36. Nicklin MJH, Weith A, Duff GW. A physical map of the region encompassing the human interleukin lot, interleukin 1β, and interleukin-1 receptor antagonist genes. Genomics 1994; 19:382-384
37. Epplen C, Frank G, Gomolka M, et al. Dinucleotide repeat polymorphism in the human IL1A gene. Hum Mol Genet 1994;3:1710
38. Diaz MO, Pomykala HM, Bohlander SK, et al. Structure of the human type-I interferon gene cluster determined from a YAC clone contig. Genomics 1994;22:540-552
39. Kwiatkowski DJ, Diaz MO. Dinucleotide repeat polymorphism at the IFNA locus (9p22). Hum Mol Genet 1992;1:658
40. Kellar-Wood HF, Wood NW, Holmans P, et al. Multiple sclerosis and the HLA-D region, linkage and association studies. J Neuroimmunol 1995;58:183-190
41. Olerup O, Hillert J, Fredrikson S, et al. Primarily chronic progressive and relapsing/remitting multiple sclerosis: two immunogenetically distinct disease entities. Proc Natl Acad Sci USA 1989;86:7113-7117
42. Crusius JBA, Pena AS, Oosten van BW, et al. Interleukin-1 receptor antagonist gene polymorphism and multiple sclerosis. Lancer 1995;346:979-980
43. Eoli M, Wood NW, Kellar-Wood HF, et al. No linkage between multiple sclerosis and the T cell receptor α chain locus. J Neurol Sci 1994;124:32-37
44. Fugger L, Sandberg-Wollheim M, Morling N, et al. The germ-line repertoire of T-cell receptor β chain genes in patients with relapsing-remitting multiple sclerosis or optic neuritis. Immunogenetics 1990;31:278-280
45. Hillert J, Leng C, Olerup O. No association with germline T cell receptor β-chain gene alleles or haplotypes in Swedish patients with multiple sclerosis. J Neuroimmunol 1991;31:141-147
46. Vandevyver C, Buyse I, Philippaerts L, et al. HLA and T-cell receptor polymorphisms in Belgian multiple sclerosis patients: no evidence for disease association with the T-cell receptor. J Neuroimmunol 1994;52:25-32
47. Lynch SG, Rose JW, Petajan JH, et al. Discordance of T-cell receptor β-chain genes in familial multiple sclerosis. Ann Neurol 1991;30:402-410
48. Wood NW, Sawcer SJ, Kellar-Wood HF, et al. The T-cell receptor β locus and susceptibility to multiple sclerosis. Neurology 1995;45:1859-1863
49. Wright S, ed. The theory of gene frequencies. Chicago: University of Chicago Press, 1969:65-119
50. Ohta T. Linkage disequilibrium due to random genetic drift in finite subdivided populations. Proc Natl Acad Sci USA 1982; 79:1940-1944
51. Thomson G, Klitz W. Disequilibrium pattern analysis. I. Theory. Genetics 1987;116:623-632
52. Beall SS, Concannon P, Charmley P, et al. The germline repertoire of T cell receptor β-chain genes in patients with chronic progressive multiple sclerosis. J Neuroimmunol 1989;21:59-66
53. Charmley P, Beall SS, Concannon P, et al. Further localization of a multiple sclerosis susceptibility gene on chromosome 7q using a new T cell receptor beta-chain DNA polymorphism. J Neuroimmunol 1991;32:231-240
54. Martinez-Naves E, Victoria-Gutierrez M, Uria DF, Lopez-Larrea C. The germline repertoire of T cell receptor β-chain genes in multiple sclerosis patients from Spain. J Neuroimmunol 1993;47:9-14
55. Seboun E, Robinson MA, Doolittle TH, et al. A susceptibility locus for multiple sclerosis is linked to the T cell receptor β chain complex. Cell 1989;57:1095-1100
56. Oksenberg JR., Panzara MA, Begovich AB, et al. Selection for T-cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 1993;362:68-73
57. Chou YK, Buenafe AC, Dedrick R, et al. T cell receptor Vβ gene usage in the recognition of myelin basic protein by cerebrospinal fluid- and blood-derived T cells from patients with multiple sclerosis. J Neurosci Res 1994;37:169-181
58. Lee JS, Wucherpfennig KW, Brod SA, et al. Common T-cell receptor Vβ usage in oligoclonal T lymphocytes derived from cerebrospinal fluid and blood of patients with multiple sclerosis. Ann Neurol 1991;29:33-40
59. Wucherpfennig KW, Ota K, Endo N, et al. Shared human T cell Vβ usage to immunodominant regions of myelin basic protein. Science 1990;248:1016-1019
60. Kotzin BL, Karuturi S, Chou YK, et al. Preferential T-cell receptor β-chain variable gene use in myelin basic protein-reactive T-cell clones from patients with multiple sclerosis. Proc Natl Acad Sci USA 1991;88:9161-9165
61. Ben-Nun A, Liblau RS, Cohen L, et al. Restricted T-cell receptor Vβ gene usage by myelin basic protein-specific T-cell clones in multiple sclerosis: predominant genes vary in individuals. Proc Natl Acad Sci USA 1991;88:2466-2470
62. Bourdette DN, Whitham RH, Chou YK, et al. Immunity to TCR peptides in multiple sclerosis. I. Successful immunization of patients with synthetic Vβ5.2 and Vβ6.1 CDR2 peptides. J Immunol 1994;152:2510-2519